Kennebec Savings Bank’s Quest Diagnostics DGX Stock Holding History

Kennebec Savings Bank’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$738K	Sell	3,482 -65	-2%	-$12.8K	0.59%	53
2026 Q1	$695K	Sell	3,547 -15	-0.4%	-$2.91K	0.62%	55
2025 Q4	$618K	Buy	3,562 +166	+5%	+$30.2K	0.53%	61
2025 Q3	$647K	Sell	3,396 -219	-6%	-$38.9K	0.59%	57
2025 Q2	$649K	Sell	3,615 -220	-6%	-$38.2K	0.64%	51
2025 Q1	$649K	Sell	3,835 -86	-2%	-$14.1K	0.69%	46
2024 Q4	$604K	Buy	3,921 +98	+3%	+$15.2K	0.61%	52
2024 Q3	$594K	Buy	+3,823	New	+$571K	0.59%	60

Other funds holding DGX

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

SIC

Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return

BCAM

Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return

Kennebec Savings Bank's DGX Position: Q2 2026 in Review

Kennebec Savings Bank reduced its Quest Diagnostics (DGX) stake by 1.8% in Q2 2026, selling an estimated $12.8K and leaving 3,482 shares worth $738K. The position accounts for 0.59% of the portfolio, ranked #53.

Kennebec Savings Bank first reported a position in DGX in Q3 2024 and has held it in 8 quarters since. 327 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Kennebec Savings Bank held 3,482 shares of Quest Diagnostics worth $738K as of Q2 2026.
Kennebec Savings Bank sold 65 Quest Diagnostics shares in Q2 2026, an estimated $12.8K.
Quest Diagnostics made up 0.59% of Kennebec Savings Bank's portfolio in Q2 2026, its #53 holding.
Kennebec Savings Bank first reported a position in Quest Diagnostics in Q3 2024 and has held it in 8 quarters since.
327 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Kennebec Savings Bank's 13F filing for Q2 2026, filed 13 Jul 2026.